MBX Biosciences, Inc. Common Stock
NASDAQ:MBXBiotechnology
-$0.64 today
- Market cap
- $2.65B
- Beta
- 0.75
- P/E (TTM)
- -22.0
- EPS (TTM)
- -$1.86
Volume 0.73M
Average 0.65M
Dividends
MBX Biosciences, Inc. Common Stock dividends
Review the payout history, yield, and how well earnings and cash flow support the dividend.
Dividends
Dividend history, growth & yield
Yield
0.00%
Annual Div/Share
$0.00
Payout Ratio
0.0%
Frequency
—
Shareholder Yield
0.00%
Next Ex-Date
Not announced
Next Payment
—
Analysis
The current indicated dividend yield is 0.00%. The payout ratio is 0.0%, so compare payout growth against earnings coverage.
Competitor dividends
How does MBX Biosciences, Inc. Common Stock compare as an income stock?
Compare dividend yield, payout ratios, and buybacks with similar companies.
Competitor Dividends
Peer payout, dividend, and buyback comparison
| Company | Market Cap | Dividend Yield | Annual Dividend | Payout Ratio | Buyback Yield |
|---|---|---|---|---|---|
Ascendis Pharma A/S NASDAQ:ASND | $18.06B | 0.00% | $0.00 | 0.00% | 0.88% |
Rhythm Pharmaceuticals, Inc. NASDAQ:RYTM | $7.97B | 0.00% | $0.00 | 0.00% | 0.00% |
Viking Therapeutics, Inc. NASDAQ:VKTX | $3.73B | 0.00% | $0.00 | 0.00% | 0.00% |
Xeris Biopharma Holdings, Inc. NASDAQ:XERS | $3.04B | 0.00% | $0.00 | 0.00% | 0.64% |
Kailera Therapeutics, Inc. NASDAQ:KLRA | $1.72B | — | $0.00 | — | 0.00% |
Altimmune, Inc. NASDAQ:ALT | $319.98M | 0.00% | $0.00 | 0.00% | 0.00% |
Oramed Pharmaceuticals Inc. NASDAQ:ORMP | $154.33M | 6.54% | $0.25 | 0.00% | 2.82% |
Biomea Fusion, Inc. NASDAQ:BMEA | $42.31M | 0.00% | $0.00 | 0.00% | 0.00% |
Questions
Dividend questions
Common questions about MBX's dividend, answered from reported figures.
Does MBX stock pay dividends?
MBX Biosciences, Inc. Common Stock (MBX) currently pays a dividend. The indicated dividend per share is 0.00 USD and the dividend yield is 0.00%.
Is MBX's dividend covered?
The payout ratio is 0.0%, so compare that against earnings and free cash flow before relying on the dividend.
Continue the stock analysis
Jump to another research area for this company.